BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31699089)

  • 1. Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer.
    Zhou M; Fan J; Li Z; Li P; Sun Y; Yang Y; Zhou X; Wang J; Wang Y; Qi H; Cai W; Dai X; Hirsch FR
    Respir Res; 2019 Nov; 20(1):248. PubMed ID: 31699089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.
    Zhou H; Hu Y; Luo R; Zhao Y; Pan H; Ji L; Zhou T; Zhang L; Long H; Fu J; Wen Z; Wang S; Wang X; Lin P; Yang H; Wang J; Song M; Yi X; Yang L; Xia X; Guan Y; Fang W; Yang Y; Hong S; Huang Y; Li P; Zhang Y; Zhou N
    Nat Commun; 2021 Sep; 12(1):5431. PubMed ID: 34521849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.
    Devarakonda S; Rotolo F; Tsao MS; Lanc I; Brambilla E; Masood A; Olaussen KA; Fulton R; Sakashita S; McLeer-Florin A; Ding K; Le Teuff G; Shepherd FA; Pignon JP; Graziano SL; Kratzke R; Soria JC; Seymour L; Govindan R; Michiels S
    J Clin Oncol; 2018 Oct; 36(30):2995-3006. PubMed ID: 30106638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlation of extensive-stage small-cell lung cancer genomics.
    Dowlati A; Lipka MB; McColl K; Dabir S; Behtaj M; Kresak A; Miron A; Yang M; Sharma N; Fu P; Wildey G
    Ann Oncol; 2016 Apr; 27(4):642-7. PubMed ID: 26802149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.
    Park S; Hong TH; Hwang S; Heeke S; Gay CM; Kim J; Jung HA; Sun JM; Ahn JS; Ahn MJ; Cho JH; Choi YS; Kim J; Shim YM; Kim HK; Byers LA; Heymach JV; Choi YL; Lee SH; Park K
    EBioMedicine; 2024 Apr; 102():105062. PubMed ID: 38492534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer.
    Ng SR; Rideout WM; Akama-Garren EH; Bhutkar A; Mercer KL; Schenkel JM; Bronson RT; Jacks T
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):513-521. PubMed ID: 31871154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
    Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
    Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer.
    Fernandez-Cuesta L; Perdomo S; Avogbe PH; Leblay N; Delhomme TM; Gaborieau V; Abedi-Ardekani B; Chanudet E; Olivier M; Zaridze D; Mukeria A; Vilensky M; Holcatova I; Polesel J; Simonato L; Canova C; Lagiou P; Brambilla C; Brambilla E; Byrnes G; Scelo G; Le Calvez-Kelm F; Foll M; McKay JD; Brennan P
    EBioMedicine; 2016 Aug; 10():117-23. PubMed ID: 27377626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset.
    Febres-Aldana CA; Chang JC; Ptashkin R; Wang Y; Gedvilaite E; Baine MK; Travis WD; Ventura K; Bodd F; Yu HA; Quintanal-Villalonga A; Lai WV; Egger JV; Offin M; Ladanyi M; Rudin CM; Rekhtman N
    Clin Cancer Res; 2022 Nov; 28(21):4702-4713. PubMed ID: 35792876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
    Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
    Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of somatic
    Yokouchi H; Nishihara H; Harada T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Nishimura M; Suzuki H; Dosaka-Akita H; Isobe H
    Heliyon; 2020 Jul; 6(7):e04439. PubMed ID: 32685741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets.
    Ouyang W; Yu J; Zeng Z; Gong J; Zhang J; Xie C
    J Thorac Dis; 2023 Dec; 15(12):6796-6805. PubMed ID: 38249912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC.
    Mohan S; Foy V; Ayub M; Leong HS; Schofield P; Sahoo S; Descamps T; Kilerci B; Smith NK; Carter M; Priest L; Zhou C; Carr TH; Miller C; Faivre-Finn C; Blackhall F; Rothwell DG; Dive C; Brady G
    J Thorac Oncol; 2020 Feb; 15(2):216-230. PubMed ID: 31629061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
    Ma W; Zhou T; Song M; Liu J; Chen G; Zhan J; Ji L; Luo F; Gao X; Li P; Xia X; Huang Y; Zhang L
    J Transl Med; 2024 Feb; 22(1):189. PubMed ID: 38383412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applied models and molecular characteristics of small cell lung cancer.
    Fűr GM; Nemes K; Magó É; Benő AÁ; Topolcsányi P; Moldvay J; Pongor LS
    Pathol Oncol Res; 2024; 30():1611743. PubMed ID: 38711976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the treatment of small cell lung cancer.
    Hiddinga BI; Raskin J; Janssens A; Pauwels P; Van Meerbeeck JP
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34261744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
    Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis.
    Yoneshima Y; Iwama E; Matsumoto S; Matsubara T; Tagawa T; Ota K; Tanaka K; Takenoyama M; Okamoto T; Goto K; Mori M; Okamoto I
    Sci Rep; 2021 Jun; 11(1):12732. PubMed ID: 34140559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left behind? Drug discovery in extensive-stage small-cell lung cancer.
    Riess JW; Lara PN
    Clin Lung Cancer; 2014 Mar; 15(2):93-5. PubMed ID: 24529447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.